# Dose-Response Study of Probiotic Bacteria BB-12 and CRL-431 in Healthy Young Adults

> **NCT00611299** · PHASE1 · COMPLETED · sponsor: **University of Copenhagen** · enrollment: 71 (—)

## Conditions studied

- Cardiovascular Disease
- Constipation

## Interventions

- **DIETARY_SUPPLEMENT:** BB-12 and CRL 431

## Key facts

- **NCT ID:** NCT00611299
- **Lead sponsor:** University of Copenhagen
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-04
- **Primary completion:** —
- **Final completion:** 2003-11
- **Target enrollment:** 71 (—)
- **Last updated:** 2008-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00611299

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00611299, "Dose-Response Study of Probiotic Bacteria BB-12 and CRL-431 in Healthy Young Adults". Retrieved via MORVS 2026-11-02 from https://api.morvs.ai/clinical/NCT00611299. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*